Atherosclerosis and Cardiovascular Diseases in Progeroid Syndromes

Area of Science:

• Gerontology
• Genetics
• Cardiovascular Medicine

Background:

• Hutchinson-Gilford progeria syndrome (HGPS) and Werner syndrome (WS) are distinct genetic progeroid syndromes.
• HGPS presents in childhood with premature aging and early death from cardiovascular disease (CVD).
• WS manifests after puberty with accelerated aging, leading to death in the 50s from CVD and cancer.

Purpose of the Study:

• To review the pathogenesis of atherosclerotic diseases in HGPS and WS.
• To discuss current and emerging treatments for these conditions.
• To leverage insights from progeroid syndromes for understanding human aging and CVD.

Main Methods:

• Review of existing literature on HGPS and WS.
• Analysis of pathogenesis mechanisms for atherosclerotic diseases in both syndromes.
• Synthesis of latest findings on treatment strategies.

Main Results:

• Both HGPS and WS serve as critical models for studying age-associated cardiovascular disease.
• Shared and distinct pathways contribute to accelerated atherosclerosis in these syndromes.
• Recent research provides novel therapeutic targets for managing CVD in progeroid conditions.

Conclusions:

• Understanding progeroid syndromes deepens our knowledge of normal human aging processes.
• Targeting specific molecular pathways in HGPS and WS may offer broader applications for CVD prevention and treatment.
• Further research into these rare diseases is crucial for advancing geriatric and cardiovascular medicine.